Grifols, S.A. GIKLY
Set alert
5.55 USD 0.00 0.00%
At close · Oct 30
5.77 Day range 5.77
5.06 52-week range 6.85
- YTD
- -9.90%
- 1 year
- -18.98%
- Open
- 5.77
- Prev close
- 5.55
- Mkt cap
- 7.55B
- Vol
- 4
- Avg vol
- 45
- EPS
- 0.38
- P/E
- 14.61
More statistics
- Low
- 5.77
- High
- 5.77
- Earnings
- Nov 10, 2026
6M chart
Events in this range
- May 7, 2026Earnings: 0.08656; estimate 0.08063; surprise 7.35%
- Jul 2, 2026Dividend: 0.047117
- Jul 28, 2026Earnings: 0.1256; estimate 0.1321; surprise -4.92%
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 2 days ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| RSI: Oversold | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| RSI: Overbought | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | May 8, 2026 | 5 months ago |
Next earnings
Nov 10, 2026
Expected Nov 10, 2026. Consensus EPS estimate 0.1426.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 10, 2026 | Sep 30, 2026 | 0.1426 | — | — | — |
| Jul 28, 2026 | Jun 30, 2026 | 0.1321 | 0.1256 | -0.01 | -4.92% |
| May 7, 2026 | Mar 31, 2026 | 0.08063 | 0.08656 | +0.01 | +7.35% |
| Feb 26, 2026 | Dec 31, 2025 | 0.1481 | 0.1446 | 0.00 | -2.36% |
| Nov 4, 2025 | Sep 30, 2025 | 0.1208 | 0.1093 | -0.01 | -9.52% |
| Aug 1, 2025 | Jun 30, 2025 | 0.1128 | 0.1001 | -0.01 | -11.26% |
News
- Oakmark International Small Cap Strategy Q2 2026 Portfolio Update
- Grifols, S.A. (GIKLY) Q2 2026 Earnings Call Transcript
- Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade)
- Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
- Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
Your note
Sign in to keep a note on GIKLY — it syncs with the Stock Master app.